Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
Ref. MDA/2005/038
Issued: 27 June 2005
| IMMEDIATE ACTION | |
| ACTION |  |
| UPDATE | |
| INFORMATION REQUEST |
| Further Information | |||||||
|---|---|---|---|---|---|---|---|
| DEVICE: Guidant CONTAK RENEWAL® (model H135) and CONTAK RENEWAL® 2 (model H155) implantable cardiac resynchronization therapy defibrillators (CRT-Ds). |
|||||||
| PROBLEM: Potential loss of cardioversion, defibrillation or pacing therapy due to diversion of high voltage shock. |
> |
||||||
| ACTION BY: All cardiologists and cardiac technicians who manage patients implanted with CONTAK RENEWAL® (model H145) or CONTAK RENEWAL® 2 (model H155) CRT-Ds. |
|||||||
| ACTION: See actions on page 3. |
> |
||||||
|
DISTRIBUTED to:
* via CE Bulletin |
> |
||||||
| CONTACTS: Details of manufacturer contacts, National Pacing and ICD Database and MHRA contacts for technical and clinical aspects. Change of address or removal from address list for Healthcare Commission. |
> |
> Further information supplied in the following pages.
MDA/2005/038 - Guidant CONTAK RENEWAL® (model H135) and CONTAK RENEWAL® 2 (model H155) implantable cardiac resynchronization therapy defibrillators (CRT-Ds). 
